Hydrocortisone, Ciprofloxacin

CIPROXINA 2 mg/ml + 10 mg/ml GOTAS OTICAS EN SUSPENSION

10 mg + 2,329 mg gotas óticas en suspensiónSpainMarketedAuthorised 26 Jul 2000

In other countries

The same active substances on other registers, the same brand first.

Cipro HC Otic SuspensionCanada · 2 MG / ML + 10 MG / ML · Suspension · Alcon Canada INCSame form
Ciproxin HC OticNew Zealand · Ear drops ciprofloxacin 0.2% with 1% hydrocortisoneSame form
Ciprobay HC Otic SuspensionSingapore · 0.2% + 1% · solution · Novartis (Singapore) Pte LTDSame form
Cipro HCUnited States · 0.2% BASE; 1% · suspension/drops · SandozSame form
Ciprofloxacin Hydrochloride and HydrocortisoneUnited States · 0.2% BASE; 1% · suspension/drops · Cosette Pharms NCSame form
OtociriaxBrazil · Farmoquímica S/ASame substance
Cipro HCBrazil · Alcon Laboratórios do Brasil Ltda.Same substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Hydrocortisone, Ciprofloxacin

CIPROXINA 2 mg/ml + 10 mg/ml GOTAS OTICAS EN SUSPENSION

10 mg + 2,329 mg gotas óticas en suspensiónSpainMarketedAuthorised 26 Jul 2000

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Cipro HCBrazil · Novartis Biociencias S.A

Packs

Pack	Code	Status
CIPROXINA 2 mg/ml + 10 mg/ml GOTAS OTICAS EN SUSPENSION , 1 frasco de 10 ml	895722

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Hydrocortisone, Ciprofloxacin
Strength: 10 mg + 2,329 mg
Dosage form: gotas óticas en suspensión
Route: vía ótica
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 26 Jul 2000
Registration: 63285
Marketing authorisation holder: Novartis Farmaceutica S.A.
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica